These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16201891)

  • 1. Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis C.
    Di Cesare E; Spadaro A; Ajello A; Ferraù O; Alessi N; Luigiano C; Melluso R; Freni MA
    Clin Chem Lab Med; 2005; 43(8):823-6. PubMed ID: 16201891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
    De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
    Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
    Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
    Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD26/30 levels before and after treatment with interferon-alpha and ribavirin combination therapy in a pediatric hepatitis C patient.
    Liao YR; Yen CP; Lin CC; Fu LS; Chiu CC; Chi CS
    J Microbiol Immunol Infect; 2004 Feb; 37(1):67-70. PubMed ID: 15060691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
    Contasta I; Berghella AM; Pellegrini P; Adorno D
    Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
    Abayli B; Canataroğlu A; Akkiz H
    Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis.
    Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A
    Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble CD30 levels in Behçet's disease.
    Düzgün N; Ayaslioglu E; Tutkak H
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S17-20. PubMed ID: 15515777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
    Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH
    Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
    El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
    Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the relationship between the serum levels of Th1/Th2 cytokines and the clinical manifestations of chronic hepatitis C and the outcome of interferon therapy].
    Zhang L; Miao L; Liu JF; Fu HC; Ma L; Zhao GZ; Dou XG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):352-4. PubMed ID: 20387484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
    Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
    J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss.
    Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H
    Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.
    Montalto G; Giannitrapani L; Soresi M; Virruso L; Martino DD; Gambino R; Carroccio A; Cervello M
    Inflammation; 2001 Apr; 25(2):101-8. PubMed ID: 11321356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
    Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.